HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Detection of preclinical Parkinson disease in at-risk family members with use of [123I]beta-CIT and SPECT: an exploratory study.

AbstractOBJECTIVE:
To explore whether the radioligand 2 beta-carboxymethoxy-3 beta-(4-[123I] iodophenyl) tropane ([123I]beta-CIT) and single-photon emission computed tomography (SPECT) can detect decreased striatal uptake in at-risk relatives of patients with Parkinson disease (PD).
PATIENTS AND METHODS:
Ten PD patients, 10 at-risk first-degree relatives of PD patients, and 10 controls underwent [123I]beta-CIT and SPECT brain imaging. Their striatal uptake ratios were compared.
RESULTS:
Age-adjusted specific to nonspecific striatal uptake ratios were lower in patients compared with controls and with relatives; however, ratios were similar in relatives and controls. Among relatives, ratios were consistently lower in subgroups postulated to be at higher risk for preclinical PD.
CONCLUSION:
Our findings provide preliminary support that [123I]beta-CIT and SPECT may detect decreased striatal uptake in relatives of PD patients postulated to be at higher risk for PD.
AuthorsD M Maraganore, M K O'Connor, J H Bower, K M Kuntz, S K McDonnell, D J Schaid, W A Rocca
JournalMayo Clinic proceedings (Mayo Clin Proc) Vol. 74 Issue 7 Pg. 681-5 (Jul 1999) ISSN: 0025-6196 [Print] England
PMID10405696 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Iodine Radioisotopes
  • 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane
  • Cocaine
Topics
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Cocaine (analogs & derivatives)
  • Corpus Striatum (diagnostic imaging)
  • Female
  • Humans
  • Iodine Radioisotopes
  • Male
  • Middle Aged
  • Parkinson Disease (diagnostic imaging)
  • Risk
  • Tomography, Emission-Computed (methods)
  • Tomography, Emission-Computed, Single-Photon (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: